Cargando…
Overview of pharmacogenomic testing in clinical practice
INTRODUCTION: Pharmacogenomic tests relevant to neuropsychiatric medications have been clinically available for more than a decade, but the utility of regular testing is still unknown. Tests available include both pharmacokinetic and pharmacodynamic targets. The potential practice benefits vary with...
Autores principales: | Gross, Tonya, Daniel, Jeremy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
College of Psychiatric & Neurologic Pharmacists
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125117/ https://www.ncbi.nlm.nih.gov/pubmed/30206507 http://dx.doi.org/10.9740/mhc.2018.09.235 |
Ejemplares similares
-
Pharmacogenomics: A focus on antidepressants and atypical antipsychotics
por: Lister, Jonathan F.
Publicado: (2016) -
Pharmacogenomics in clinical trials: an overview
por: Nogueiras-Álvarez, Rita
Publicado: (2023) -
Pharmacogenomics for Primary Care: An Overview
por: Rollinson, Victoria, et al.
Publicado: (2020) -
Psychiatric pharmacogenomic testing in clinical practice
por: Mrazek, David A.
Publicado: (2010) -
Impact of Pharmacogenomics in Clinical Practice
por: Principi, Nicola, et al.
Publicado: (2023)